Announcement of Intent To Award Three OPDIV-Initiated Supplements for Grantees Under the Direct Services for Survivors of Torture Program

Citation84 FR 52884
Record Number2019-21518
Published date03 October 2019
SectionNotices
CourtChildren And Families Administration,Health And Human Services Department
Federal Register, Volume 84 Issue 192 (Thursday, October 3, 2019)
[Federal Register Volume 84, Number 192 (Thursday, October 3, 2019)]
                [Notices]
                [Pages 52884-52885]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2019-21518]
                =======================================================================
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                Administration for Children and Families
                [CFDA Number: 93.604]
                Announcement of Intent To Award Three OPDIV-Initiated Supplements
                for Grantees Under the Direct Services for Survivors of Torture Program
                AGENCY: Office of Refugee Resettlement (ORR), Administration for
                Children and Families (ACF), Department of Health and Human Services
                (HHS).
                ACTION: Notice of intent to issue three OPDIV-Initiated Supplements.
                -----------------------------------------------------------------------
                SUMMARY: The ACF, ORR, Division of Refugee Health announces the intent
                to award three OPDIV-Initiated Supplements in the amount of $67,724 to
                each of three current grantees providing direct services funded through
                the Services for Survivors of Torture (SOT) Program.
                DATES: The proposed period of support for the supplements begins on
                September 30, 2019, and ends on September 29, 2020.
                FOR FURTHER INFORMATION CONTACT: Curi Kim, Division Director, Division
                of Refugee Health, Office of Refugee Resettlement, 330 C Street SW,
                Washington, DC 20201. Telephone: 202-401-5585. Email:
                [email protected].
                SUPPLEMENTARY INFORMATION: Three grantees that are located in states
                which have the greatest need for services will receive supplements to
                enhance their capacity to serve survivors of torture within the scope
                of their original proposed activities. The table below shows the
                grantees, location, and supplemental award amount.
                ----------------------------------------------------------------------------------------------------------------
                 Supplement
                 Organization City State amount
                ----------------------------------------------------------------------------------------------------------------
                Program for Torture Victims.............. Los Angeles................. CA $67,724
                Gulf Coast Jewish Family and Community Clearwater and Miami........ FL 67,724
                 Services, Florida Center for Survivors
                 of Torture.
                Center for Survivors of Torture.......... Dallas...................... TX 67,724
                ----------------------------------------------------------------------------------------------------------------
                [[Page 52885]]
                 Authority: Torture Victims Relief Act of 1998, Section 5(a),
                Pub. L. 105-320 (22 U.S.C. 2152 note).
                Elizabeth Leo,
                Senior Grants Policy Specialist, Division of Grants Policy, Office of
                Administration.
                [FR Doc. 2019-21518 Filed 9-30-19; 11:15 am]
                BILLING CODE 4184-45-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT